What Does Kallyope Do?

Total employees71
HeadquartersNew York
Founded2015

Kallyope is a clinical-stage biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. Founded in 2015 by Charles Zuker, Tom Maniatis, and Richard Axel, Kallyope leverages a sophisticated platform that integrates advanced technologies such as sequencing, bioinformatics, cellular and molecular biology, and human genetics to identify and validate novel targets and develop gut-restricted oral small-molecule drugs. The company focuses on major unmet medical needs in areas including metabolic disorders (like obesity and diabetes), gastrointestinal conditions, and central nervous system disorders. By understanding the complex communication between the gut and the brain, Kallyope aims to create transformative medicines that act locally in the gut to achieve systemic effects with improved safety and efficacy.

Where Is Kallyope's Headquarters?

HQ Function

The headquarters serves as the central hub for Kallyope's research and development operations, including drug discovery, translational science, clinical development, as well as corporate functions like business development, finance, and administration.

Notable Features:

Situated in the Alexandria Center for Life Science, the facility boasts state-of-the-art laboratories, cutting-edge research equipment, and modern office spaces designed to foster collaboration and innovation. The center itself is known for its vibrant scientific community and shared amenities.

Work Culture:

Kallyope fosters a highly collaborative, science-driven, and innovative work environment. The culture emphasizes rigorous scientific inquiry, teamwork, and a shared passion for translating groundbreaking discoveries into impactful therapies for patients. Being in NYC offers a dynamic and diverse talent pool.

HQ Significance:

The location in New York City, specifically within a premier life science campus, provides Kallyope with access to world-class academic institutions, a rich talent pool, potential collaborators, and a strong investor community, all crucial for a growing biotech company.

Values Reflected in HQ: The headquarters reflects Kallyope's commitment to scientific excellence, innovation, and collaboration, providing an environment conducive to cutting-edge research and development.

Location:

While Kallyope's physical operations are primarily centered in its New York City headquarters, its research and development efforts have a global outlook. The company designs clinical trials that may involve sites internationally to reach diverse patient populations and collaborates with researchers and institutions worldwide. Their therapeutic candidates are intended for global markets upon approval.

Street Address:

430 East 29th Street, 14th Floor

City:

New York

State/Province:

NY

Country:

USA

Where Else Does Kallyope Operate Around the World?

No additional office locations available.

Buying Intent Signals for Kallyope

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Kallyope? Meet the Executive Team

As of April 2025, Kallyope' leadership includes:

Jay Galeota - President and Chief Executive Officer
Nancy Thornberry - Chair, Scientific Advisory Board and Advisor
Brett Lauring, M.D., Ph.D. - Chief Medical Officer
Ann D. Kwong, Ph.D. - Chief Development Officer & Head of Translational Medicine
Bill DeWaele - Chief Business Officer
Shirly Pinto, Ph.D. - Chief Scientific Officer

Who's Investing in Kallyope?

Kallyope has been backed by several prominent investors over the years, including:

The Column Group
Lux Capital
Polaris Partners
Illumina Ventures
Alexandria Venture Investments
Euclidean Capital
Two Sigma Ventures
Bill Gates
Casdin Capital
StepStone Group

What Leadership Changes Has Kallyope Seen Recently?

Hire0
Exits0

Based on public announcements, Kallyope has maintained stability in its core executive team over the past 12 months, with no major C-suite hires or departures widely reported. The company continues to build out its scientific and development teams.

What Technology (Tech Stack) Is Used byKallyope?

Discover the tools Kallyope uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Kallyope Email Formats and Examples

Kallyope likely uses common corporate email formats. The most probable formats are [first_initial][last]@kallyope.com or [first].[last]@kallyope.com. These are standard in the biotechnology and pharmaceutical industries.

flast@kallyope.com, first.last@kallyope.com

Format

jgaleota@kallyope.com

Example

80%

Success rate

What's the Latest News About Kallyope?

Kallyope Press ReleaseMay 2, 2024

Kallyope to Present New Data on its Anorexia and Obesity Programs at the 2024 Digestive Disease Week (DDW) Conference

Kallyope announced it will present new preclinical data on its programs targeting anorexia and obesity at the Digestive Disease Week (DDW) Conference, May 18-21, 2024, in Washington D.C. The presentations will highlight novel gut-restricted compounds and their mechanisms....more

Kallyope Press ReleaseNovember 2, 2023

Kallyope to Present New Data on its Metabolic Portfolio at ObesityWeek® 2023

Kallyope announced multiple oral and poster presentations at ObesityWeek® 2023, held October 14-17 in Dallas, TX. The presentations featured new data on Kallyope’s portfolio of gut-restricted small molecules for obesity and related metabolic disorders, including programs targeting GLP-1, GIP, and GDF15 pathways....more

Kallyope Press ReleaseJanuary 5, 2023

Kallyope Announces Appointment of Shirly Pinto, Ph.D., as Chief Scientific Officer

Kallyope announced the appointment of Shirly Pinto, Ph.D., as Chief Scientific Officer. Dr. Pinto brings extensive experience in drug discovery and development, particularly in neuroscience and metabolic diseases, from her previous roles at Teva Pharmaceuticals and other biotech companies....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Kallyope, are just a search away.